Pages that link to "Q57778551"
Jump to navigation
Jump to search
The following pages link to Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice (Q57778551):
Displaying 50 items.
- Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease (Q24250271) (← links)
- Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life (Q33529282) (← links)
- Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life (Q33755801) (← links)
- Corticosteroids in chronic obstructive pulmonary disease. Clinical benefits and risks (Q34149567) (← links)
- Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease (Q34512896) (← links)
- An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease: the research protocol of the Home Sweet Home study (Q34573458) (← links)
- One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. (Q34609913) (← links)
- Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic Phenotypes (Q35249531) (← links)
- Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care (Q35533974) (← links)
- Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study (Q35536623) (← links)
- Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. (Q35537270) (← links)
- Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review (Q35753636) (← links)
- Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. (Q35885146) (← links)
- Moxifloxacin in respiratory tract infections (Q36066098) (← links)
- Differences in COPD-related readmissions to primary and secondary care hospitals (Q36135425) (← links)
- COPD exacerbations .1: Epidemiology (Q36183861) (← links)
- Periodontal status and oral health behavior in hospitalized patients with chronic obstructive pulmonary disease (Q36242552) (← links)
- EMPADE Study: Evaluation of Medical Prescriptions and Adverse Drug Events in COPD Patients Admitted to Intensive Care Unit (Q36343488) (← links)
- Effect of intervention promoting a reduction in antibiotic prescribing by improvement of diagnostic procedures: a prospective, before and after study in general practice (Q36591356) (← links)
- Geographic differences in clinical characteristics and management of COPD: the EPOCA study (Q37115955) (← links)
- The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease (Q37221196) (← links)
- Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. (Q37224498) (← links)
- How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study (Q37496448) (← links)
- Efficacy of tiotropium in the prevention of exacerbations of COPD. (Q37555782) (← links)
- Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium (Q37724621) (← links)
- Acute exacerbations of COPD: recommendations for integrated care (Q37754888) (← links)
- Impact of exacerbations on COPD (Q37801167) (← links)
- Chronic obstructive pulmonary disease (COPD) and old age? (Q37877440) (← links)
- Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study (Q38819989) (← links)
- Clinical correlations of computed tomography imaging in chronic obstructive pulmonary disease (Q39305065) (← links)
- Predictors for antibiotic prescribing in patients with exacerbations of COPD in general practice (Q40260675) (← links)
- Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP study (Q40353937) (← links)
- Antibiotic prescribing in respiratory tract infections and predictive factors for their use (Q40381446) (← links)
- General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled tria (Q42172274) (← links)
- Answers to 5 common questions about acute exacerbations of COPD. (Q43263702) (← links)
- Treatment and quality of life in patients with chronic obstructive pulmonary disease (Q44042604) (← links)
- The cost of chronic obstructive pulmonary disease in Spain: options for optimizing resources (Q44126868) (← links)
- Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols (Q44442777) (← links)
- Update to the Latin American Thoracic Association (ALAT) Recommendations on Infectious Exacerbation of Chronic Obstructive Pulmonary Disease (Q44957842) (← links)
- Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC) (Q45271359) (← links)
- Evaluation of the effectiveness of hospital discharge planning and follow-up in the primary care of patients with chronic obstructive pulmonary disease. (Q45938569) (← links)
- Previous outpatient antibiotic use in patients admitted to hospital for COPD exacerbations: room for improvement (Q47241955) (← links)
- Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment (Q47755387) (← links)
- Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. (Q50739554) (← links)
- Disease severity and symptoms among patients receiving monotherapy for COPD. (Q53062786) (← links)
- Factors determining the quality of life of patients with COPD in primary care. (Q53119071) (← links)
- [Effectiveness of a specific program for patients with chronic obstructive pulmonary disease and frequent exacerbations] (Q57217059) (← links)
- Tratamiento antimicrobiano de la agudización de la EPOC: Documento de Consenso 2007 (Q57778142) (← links)
- Antimicrobial Treatment of Exacerbation in Chronic Obstructive Pulmonary Disease: 2007 Consensus Statement (Q57778146) (← links)
- Moxifloxacin: a respiratory fluoroquinolone (Q57778170) (← links)